Part III · Aging beautifully
Menopause, Hormones, and Skin
The hormonal skin changes women are rarely warned about, and what can help.
I want to spend a whole chapter on this because the conversation isn't happening often enough, and the women going through it are confused, frustrated, and often dismissed.
In my practice, I see women in their forties and fifties who come in describing their skin in language that almost sounds like grief. "It's not my face anymore." "I look so much older than I did a year ago." "Nothing I'm doing is working." "What happened to me?"
What happened, in most cases, is perimenopause and menopause. The skin changes are real, they're dramatic, they're hormonally driven, and they often catch women completely off guard because nobody told them what to expect.
This chapter is for them. It's also for younger women who'll be there in a decade and deserve to be prepared. And it's for everyone, men included, who has someone in their life going through this and wants to understand it better.
I'm going to write this chapter the way I'd talk to a patient in my office. With the family practice context I bring to aesthetics, with the willingness to discuss things that some providers don't, and with the practical recommendations that actually help.
What's Actually Happening Hormonally
Menopause is defined as twelve consecutive months without a menstrual period. The average age of natural menopause in the US is fifty-one, though it varies widely.
Perimenopause is the years leading up to menopause when hormone levels become erratic and symptoms begin. This can start as early as the late thirties for some women, more commonly the early to mid-forties. Perimenopause can last anywhere from a few years to a decade.
The post-menopausal period is the rest of life after menopause. The hormonal pattern is different from both reproductive years and perimenopause: estrogen and progesterone are at low, stable, post-reproductive levels.
What's happening to your hormones:
Estrogen declines significantly, though in irregular and unpredictable patterns during perimenopause and then to a low stable level after menopause.
Progesterone declines similarly.
Androgens (including testosterone) decline more gradually. Because estrogen drops faster than androgens, the relative ratio of androgens to estrogen shifts, which is why some women experience androgen-driven symptoms like acne, oily skin, or increased facial hair during this transition.
Thyroid function can also shift during this period, complicating the picture.
What Your Skin Is Doing
Estrogen is profoundly important for skin. Estrogen receptors are present throughout the skin. Estrogen supports collagen production, skin thickness, hydration, wound healing, sebum production (in a balancing way), and barrier function.
When estrogen drops, all of these are affected.
Collagen loss accelerates. The decline that's been happening at about one percent per year since your mid-twenties suddenly jumps. In the first five years after menopause, women lose about thirty percent of their skin collagen. Thirty percent. In five years.
Skin thins significantly. The dermal layer, where collagen lives, becomes measurably thinner. The skin starts to look more transparent in some areas, with visible vessels and a more crepe-like texture.
Hydration drops. Sebum production decreases. The skin barrier becomes more compromised. Women who never had dry skin suddenly experience dryness for the first time.
Wound healing slows. Small injuries take longer to recover. Procedures that were tolerated well in the forties may have more prolonged recovery in the fifties.
Skin becomes more sensitive. Products that previously worked may start to irritate. Reactivity increases.
Hyperpigmentation can worsen. Melasma may flare. Sun damage that was already present may become more visible.
Acne can return, paradoxically. With estrogen dropping faster than androgens, the relative androgen excess can trigger oil production and acne in women who haven't had it in decades. Often on the jawline and chin.
Facial hair may increase. The same relative androgen pattern that drives acne can also drive hair growth on the chin and upper lip. This is normal but rarely discussed.
These changes don't happen in a smooth gradient. For many women, they appear suddenly. The skin that was fine in late perimenopause can change dramatically in the first year or two after menopause. Patients describe feeling like they aged ten years overnight.
Why You Probably Weren't Warned
Most of what happens to women's bodies during menopause is undertaught in medical training. Most providers don't have detailed conversations with their patients about it. Most patients don't have the language to bring it up themselves, beyond hot flashes and mood changes.
The skin specifically is rarely part of the menopause conversation. Doctors talk about hot flashes, sleep disruption, mood symptoms, vaginal changes, and bone health. The skin changes are often treated as a cosmetic afterthought, or attributed vaguely to "aging" rather than to the specific hormonal mechanism causing them.
This means many women experience these changes without context. They don't know what's happening. They don't know that interventions exist. They sometimes blame themselves for not doing enough or not using the right products.
It's not your fault. It's your hormones. And there are real things you can do.
Topical Strategies
Skincare during and after menopause needs to shift to address what's happening. The routine that worked at thirty-five often needs to be reconsidered at fifty.
Priorities shift toward:
Barrier repair and hydration. Ceramide-rich moisturizers become non-negotiable. The skin can't maintain its barrier the way it could before. Help it.
Gentler actives. The retinoid you tolerated at thirty might be too aggressive now. Consider a gentler retinoid, less frequent use, or a switch to retinaldehyde. Strong AHAs may become too irritating. Niacinamide and peptides become more valuable.
Strategic biostimulators. Topical peptides, growth factors, and other ingredients that signal the skin to produce collagen become more relevant when the body's own signal has dropped.
Sunscreen and antioxidants. Even more critical now because the skin is more vulnerable and less resilient.
Heavier moisturization, particularly at night. Cream-based formulations with multiple humectants and occlusives. Facial oils as final layer can help.
A note on retinoid use during menopause: some women's skin becomes too reactive for the retinoid that previously worked. If your retinoid is causing more irritation than benefit, dial back. Use less frequently. Switch to a gentler form. Don't abandon retinoids entirely, but adjust to what your skin can handle.
In-Office Treatments for Menopausal Skin
Several treatment categories become particularly relevant during and after menopause:
Collagen-stimulating treatments. Sculptra, hyperdilute Radiesse, polynucleotides, microneedling RF, and laser resurfacing all stimulate collagen production. These directly address the underlying mechanism of menopausal skin changes.
Skin quality treatments. Lasers (fractional non-ablative), peels, IPL, and skin boosters help maintain skin quality as the natural quality declines.
Volume restoration. Filler placed thoughtfully can replace some of the volume lost to bone remodeling and fat pad changes. Conservative placement matters more than ever.
Energy-based tightening. Ultherapy, Thermage, RF microneedling can address mild laxity that's becoming visible.
The strategy in this period is different from earlier decades. It's less about specific concerns and more about maintaining overall skin health and structure as the body's hormonal support has shifted.
I'd urge particular care with aggressive treatments during this period. Healing is slower. Inflammation may persist longer. Pigmentation complications may be more likely. The patient who tolerated significant procedures at forty may not have the same recovery at fifty-five.
Hormone Replacement Therapy: The Bigger Conversation
I want to address HRT specifically because it sits at the intersection of medicine and aesthetics in important ways.
Hormone replacement therapy, specifically estrogen therapy (with progesterone for women with a uterus), can address many of the skin changes of menopause. The benefits include:
Slower collagen loss. Studies show preservation of skin thickness and collagen with HRT compared to no treatment.
Better skin hydration. Estrogen supports the skin's ability to retain water.
Reduced sensitivity and improved barrier function over time.
Improvement in many of the other menopausal symptoms (hot flashes, sleep, mood, bone density, urogenital health), which indirectly support skin health.
The history of HRT is complicated. After the Women's Health Initiative study published initial findings in 2002, HRT was widely abandoned because of concerns about cardiovascular and cancer risks. The interpretation of that study has since been significantly revised, and the current understanding is that HRT for appropriate candidates, started at appropriate times, has a much more favorable risk-benefit profile than was thought.
The current research suggests:
Women starting HRT within ten years of menopause or before age sixty likely have favorable risk-benefit profiles.
The route of administration matters. Transdermal estrogen (patches, gels) has different risk profiles than oral estrogen.
Different formulations have different effects.
HRT isn't appropriate for everyone. Specific cancers, blood clot history, and other conditions may contraindicate it.
I'm not going to tell you whether you should be on HRT. That's a conversation between you and a knowledgeable physician who can review your specific health history and risk factors. What I am telling you is that if you've been told to just "tough it out" through menopause without considering HRT, you may not be getting current information.
Look for a provider who's up to date on menopause medicine. Not every primary care doctor is. The North American Menopause Society maintains a directory of certified menopause practitioners, which can be a good starting point.
The intersection with aesthetics is real. Women on HRT often see better outcomes from aesthetic procedures, better baseline skin quality, and slower progression of skin aging compared to women who aren't. This isn't a reason to take HRT, but it is a meaningful consideration that often isn't part of the conversation.
Going Deeper on HRT Options
Since I'm talking about HRT, let me get more specific about the choices women face when they pursue this conversation, because the landscape is more complex than "should I or shouldn't I."
Estrogen routes of administration.
Oral estrogen (pills) goes through the liver before reaching the rest of the body. This first-pass metabolism affects how the body handles the hormone and creates some metabolic byproducts. The oral route is associated with slightly higher risks of blood clots compared to other routes, which becomes more relevant in patients with cardiovascular risk factors.
Transdermal estrogen (patches, gels, sprays) bypasses the liver and delivers estrogen directly into the bloodstream through the skin. This route avoids the first-pass effects and is generally considered to have a more favorable safety profile, particularly for cardiovascular and clotting concerns. Many menopause specialists prefer transdermal options as a first choice for new HRT users.
Vaginal estrogen comes in creams, rings, and tablets used directly in the vagina. The systemic absorption is very low, so vaginal estrogen primarily addresses local symptoms (vaginal dryness, painful intercourse, urinary symptoms) without significantly affecting the rest of the body. It's safe even for many women who can't take systemic HRT.
Estrogen formulations.
Estradiol is bioidentical to the estrogen your ovaries produced before menopause. Available in oral pills, patches, gels, sprays, and vaginal forms. Most current HRT prescribing favors estradiol as a first choice.
Conjugated equine estrogens (CEE, sold as Premarin) are derived from pregnant mares' urine and contain a mixture of estrogens, some of which aren't naturally produced by humans. This was the most commonly prescribed estrogen for decades and was used in the Women's Health Initiative study. It works, but the side effect and risk profile differs slightly from estradiol.
Ethinyl estradiol is a synthetic estrogen primarily used in oral contraceptives, not typically used for menopause HRT in current practice.
Progesterone considerations.
If you have a uterus and take systemic estrogen, you need progesterone to protect the uterine lining from the cancer risk that unopposed estrogen creates. Women without a uterus (after hysterectomy) typically don't need progesterone for HRT.
Micronized progesterone (Prometrium) is bioidentical and is generally preferred in current practice. It can be taken orally, often at bedtime since it tends to be sedating, which can be a side benefit for sleep.
Synthetic progestins like medroxyprogesterone acetate (Provera) are older formulations. They work but have a slightly different side effect profile than bioidentical progesterone.
Some women use combination products that include both estrogen and progestin. Others take each separately, which allows more flexibility in dosing.
"Bioidentical" hormones: marketing versus reality.
You'll hear a lot about "bioidentical hormones" and "compounded" hormones. Let me clarify some confusion.
Bioidentical means the molecular structure is identical to what your body naturally produces. Estradiol and micronized progesterone, when prescribed through standard pharmacy channels, are bioidentical. So the FDA-approved hormones available at any pharmacy already are bioidentical in most cases.
Compounded hormones are made by compounding pharmacies that mix custom formulations. They're often marketed as superior to "standard" HRT because they're "individualized" or "bioidentical." This marketing is mostly misleading. Compounded hormones aren't regulated the same way as FDA-approved hormones. There's less quality control, less consistency between batches, and less safety data. They're not actually more bioidentical than the standard prescription hormones.
There are legitimate uses for compounded formulations, such as patients with specific allergies or who need unusual dose combinations. For most patients, standard FDA-approved bioidentical hormones from a regular pharmacy are the better choice.
If a provider is pushing you toward expensive compounded hormone protocols, particularly with claims about how they're superior to "regular" HRT, that's worth questioning. The Menopause Society and other professional organizations have spoken out against the over-marketing of compounded hormones.
Testosterone in women's HRT.
This is an area where evidence is still developing. Women do produce small amounts of testosterone before menopause, and levels drop with age. Some women report improvements in energy, libido, mood, and possibly cognitive function with low-dose testosterone replacement.
The current evidence supports using testosterone for low libido in menopausal women when other causes have been ruled out. Other benefits are still being studied. There's no FDA-approved testosterone product specifically for women in the US, which means it's prescribed off-label. Some providers use compounded testosterone creams; some use very low doses of male testosterone formulations.
If you're considering testosterone, work with a menopause specialist who can monitor levels and adjust appropriately. Testosterone at too-high doses in women can cause unwanted effects including acne, oily skin, facial hair growth, and irreversible changes to voice.
Dosing approaches.
There's a clinical philosophy around starting HRT at the lowest effective dose and adjusting based on symptoms and response. Some patients need higher doses to feel like themselves. Others do well on lower doses. The right answer is individual.
The timing question matters too. Starting HRT close to the natural age of menopause appears to have a better risk-benefit profile than starting much later. This doesn't mean older women can't benefit from HRT, but the conversation may be different for someone in her seventies versus someone in her fifties.
Length of treatment.
The old framework was "as little as possible, for as short as possible." Current thinking has shifted. Many women can take HRT for years or even longer if it continues to benefit them and they remain good candidates. The decision to continue or stop should be revisited periodically with a knowledgeable provider, not just assumed to follow a strict timeline.
When HRT isn't appropriate.
Some conditions make HRT generally inappropriate or higher risk:
History of hormone-receptor positive breast cancer.
History of certain other cancers (some uterine cancers, others depending on hormone receptor status).
Active or recent blood clots.
Active liver disease.
Certain cardiovascular conditions.
Unexplained vaginal bleeding before it's been evaluated.
These aren't all absolute contraindications. The decision depends on individual circumstances, and some patients in these categories can still use certain HRT formulations under appropriate supervision. The conversation needs a knowledgeable provider, not a blanket rule.
Topical Hormonal Therapies for Skin
Beyond systemic HRT, there's emerging interest in topical hormonal treatments specifically for skin.
Topical estrogen creams have been studied for menopausal skin changes. The evidence shows improvements in skin thickness, hydration, and collagen content with prolonged use. The catch is that the creams contain prescription-strength estrogen and aren't FDA-approved for cosmetic use. Some providers prescribe them off-label for specific patients with informed consent about the off-label nature.
Topical DHEA (a hormone precursor) has been used for facial skin in some research settings. The evidence is developing but suggests possible benefit for skin quality. Several products in the cosmeceutical market contain DHEA, with variable formulations and effects.
These options are still relatively niche. Most patients are better served by systemic HRT (if appropriate) plus excellent topical skincare than by trying to address skin changes with specialized hormonal creams.
What I Tell Patients Considering HRT
A few points I emphasize in these conversations.
This isn't a one-size-fits-all decision. Your body, your history, your priorities, and your risk factors all matter.
Find a provider who's current on the evidence. Not every primary care doctor or gynecologist has stayed updated on the post-WHI re-analysis and current consensus. The Menopause Society maintains a directory of certified menopause practitioners. The provider you've been seeing for years may or may not be the right resource for this conversation.
The fear of HRT that took hold after 2002 was based on incomplete information. Many women who'd benefit are afraid to consider it because of messaging from that era. The evidence has evolved significantly. Make your decision based on current evidence, not legacy fears.
HRT isn't just about skin. The full benefits and risks span cardiovascular health, bone density, mood, cognition, sexual function, and overall quality of life. Make this decision in the broader context, not just for cosmetic reasons.
It's okay to try HRT and stop if it's not right for you. It's okay to start later if it's not right for you now. It's okay to never start. Whatever you decide, make it an informed decision.
What I Don't Want You to Do
A few things I see during this period that I'd discourage:
Don't catastrophize. This is a normal life transition. Your face is changing, but you're not falling apart. The visible changes can be slowed, mitigated, and worked with. Your value isn't being lost.
Don't blame yourself. The changes are hormonal. They would have happened regardless of your skincare or lifestyle. You're not failing at aging because your face looks different than it did at thirty-five.
Don't try to chase the face you had at thirty. This is one of the most common mistakes. Filler and procedures used aggressively to recreate a younger face usually produce uncanny results, not refreshed ones. Aim for a beautiful version of your actual age, not a recreation of your younger face.
Don't dismiss your feelings about it either. Some women feel real grief about the changes of this period. The cultural messaging about women aging is brutal. The skin changes can feel like losing yourself, even when you know they're normal. These feelings are valid and worth addressing, sometimes with therapy or community support.
Don't isolate. Talk to other women going through this. There's enormous shared experience and wisdom in those conversations. Online communities, friends, family, and menopause-specific support groups can all help.
What I'd Like You to Do
A different list:
Get educated about menopause. Read about what's happening physiologically. Books like "The Menopause Brain" by Lisa Mosconi or "The New Menopause" by Mary Claire Haver are excellent. Understand the changes you're experiencing.
Find providers who understand this transition. Your skincare provider should know how to adjust your routine and treatments for menopausal skin. Your physician should be knowledgeable about HRT and menopause medicine. If yours aren't, look for others.
Reassess your skincare with this context in mind. What worked at forty may not be what you need at fifty-five. Be willing to adjust.
Consider the bigger picture. The skin changes are one part of a larger transition that affects multiple systems. Address all of it, not just the visible parts. Bone health, cardiovascular health, mood, sleep, sexual health.
Take care of yourself with kindness. This is a major life transition. You deserve support, attention, and self-compassion. The face changes are real, but you are still you, in many ways more you than ever.
A Note on Surgical Menopause and Early Menopause
If you've gone through surgical menopause (hysterectomy with oophorectomy) or premature menopause (before age forty), the skin changes can be more abrupt and more dramatic. The drop in estrogen is sudden rather than gradual.
These situations warrant particular attention to hormone management. Women who experience early menopause typically benefit from HRT until at least the natural age of menopause, often longer. The skin implications are part of why.
If you're in this situation, work with a provider who has specific experience in early menopause. Standard menopause protocols may not be appropriate for you.
A Final Note
Menopause is one of the most under-supported transitions in women's lives. Medical education has historically underprepared providers. Cultural narratives have shamed women into silence about it. The skin and aesthetic conversations are often dismissed as vain.
I'd reject all of that.
Your body is changing in ways that are profound and have real consequences. Your skin is part of that. Wanting to understand it, address it, and feel good in your own face is not vanity. It's self-care.
If you're going through this and feeling alone or confused, please know that the experience is shared by every woman who reaches this stage of life. There are real interventions, real treatments, and real providers who can help. You don't have to figure it out alone.
The next chapter takes the conversation in a different direction. Skin and mental health. When skincare crosses from self-care into something more concerning. The conversation about dysmorphia, the patient who can't stop seeing flaws, and the moment when the right answer is a therapist rather than another syringe.